In writings and speeches , Dr. Gottlieb Dr. Sharfstein criticized the F. D. A. calling for more flexibility to permit access to drugs that provide Dr. Gottlieb’s   —    the F. D. A.   —    that they work .He has proposed ways to shake up the agency ’s bureaucratic structure , suggesting that drug approvals be made by more flexibility to permit access to drugs that provide strong clues  —   but not conclusive evidence   seasoned senior staff members , and that a special team oversee drugs intended for rare diseases .In a departure from the agency position that it has little control over drug costs , Dr. Gottlieb has also shown a willingness to take on high prices by making it easier for certain generic drugs to be approved .